Social Media Influencers Driving Parallel Market for Unapproved Slimming Medication
An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Traction Online
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and claims of rapid British shipping. Vendors promote the drug there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Worries
However, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting products of unknown origin.
Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer regulations, risking penalties, legal action or prison.
Service Response and Content Elimination
According to TikTok, the platform has removed problematic content and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, filled with images of slimming results, glowing reviews and step-by-step instructions for mixing or administering at residence.
After minutes of joining one community, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.
Product Details and Pricing
Inside these groups, messages display black plastic packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how much time a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service said it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering materials they can’t verify. Although the research behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has already encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to potentially serious medical dangers”.
